Hard to tell because some values are mean vs. median, but it may be that BETonMACE patients have lower LDL-C and lower HbA1c compared to EXAMINE patients. Example of better standard of care for LDL-C lowering and glucose control?

eGFR of <60 ml/min less prevalent in total BETonMACE patients compared to EXAMINE (though there is CKD subgroup on those 11% in BETonMACE).

HDL-C is also hard to compare since it is mean vs. median, but BETonMACE should end up having lower mean HDL-C than the 43 mg/dL in EXAMINE.